Position in PTGX
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$1,104,486
-$425,797 QoQ
Shares Held
10,479
-40.2% QoQ
Ownership
0.016%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2024
4 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PTGX Over Time
Shares Held
Position Value (USD)
Derivatives in PTGX
reported options exposure · as of Jun 30, 2025CallValue
$0
CallShares
0
PutValue
$2,763,500
PutShares
50,000
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026NOMURA HOLDINGS INC holds $218,808,046 across 46 Biotechnology names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | IONS |
Ionis Pharmaceuticals Inc
|
402,192 | $31,889,803 | |
| 2 | BBIO |
BridgeBio Pharma, Inc.
|
327,475 | $24,390,338 | |
| 3 | LGND |
Ligand Pharmaceuticals Inc
|
61,938 | $19,577,982 | |
| 4 | AUPH |
Aurinia Pharmaceuticals Inc.
|
978,602 | $16,606,875 | |
| 5 | HRMY |
Harmony Biosciences Holdings, Inc.
|
417,932 | $15,216,904 | |
| 6 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
29,198 | $14,503,522 | |
| 7 | OABI |
OmniAb, Inc.
|
5,028,160 | $12,369,273 | |
| 8 | REGN |
Regeneron Pharmaceuticals, Inc.
|
14,320 | $8,929,092 |
All Filings in PTGX
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,104,486 | 10,479 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $1,530,283 | 17,521 | Shares | Defined | 2026-02-17 | |
| 2025-06-30 | $2,763,500 | 50,000 | Put | Defined | 2025-08-18 | |
| 2025-06-30 | $409,882 | 7,416 | Shares | Defined | 2025-08-18 | |
| 2024-09-30 | $367,155 | 8,159 | Shares | Defined | 2025-01-13 | |
| No filing history on record for this holder in this stock. | ||||||